BMO Capital Markets began coverage on shares of American Healthcare REIT (NYSE:AHR – Free Report) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The firm issued an outperform rating and a $55.00 price target on the stock.
Other research analysts also recently issued reports about the company. Citigroup increased their target price on American Healthcare REIT from $45.00 to $52.00 and gave the company a “neutral” rating in a research report on Friday, November 21st. UBS Group increased their price objective on shares of American Healthcare REIT from $51.00 to $56.00 and gave the company a “buy” rating in a research report on Monday, November 17th. Truist Financial dropped their price objective on shares of American Healthcare REIT from $53.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, January 20th. Citizens Jmp upped their target price on shares of American Healthcare REIT from $50.00 to $60.00 and gave the company a “market outperform” rating in a research report on Monday, November 10th. Finally, Scotiabank lifted their price target on American Healthcare REIT from $47.00 to $55.00 and gave the stock a “sector outperform” rating in a research report on Thursday, November 13th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, American Healthcare REIT has an average rating of “Moderate Buy” and a consensus price target of $51.83.
Get Our Latest Analysis on AHR
American Healthcare REIT Stock Performance
American Healthcare REIT Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 16th. Investors of record on Wednesday, December 31st were issued a dividend of $0.25 per share. The ex-dividend date was Wednesday, December 31st. This represents a $1.00 dividend on an annualized basis and a yield of 2.1%. American Healthcare REIT’s payout ratio is presently 714.29%.
Insider Transactions at American Healthcare REIT
In other news, Director Jeffrey T. Hanson sold 35,570 shares of the firm’s stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $48.38, for a total transaction of $1,720,876.60. Following the transaction, the director directly owned 19,208 shares of the company’s stock, valued at approximately $929,283.04. This trade represents a 64.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Mark E. Foster sold 1,500 shares of American Healthcare REIT stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $49.35, for a total transaction of $74,025.00. Following the sale, the executive vice president directly owned 57,600 shares of the company’s stock, valued at $2,842,560. This represents a 2.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 76,288 shares of company stock worth $3,718,666. Company insiders own 0.92% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the company. Optiver Holding B.V. grew its stake in American Healthcare REIT by 83.1% in the third quarter. Optiver Holding B.V. now owns 652 shares of the company’s stock valued at $27,000 after purchasing an additional 296 shares during the last quarter. Trust Co. of Vermont bought a new stake in shares of American Healthcare REIT in the 3rd quarter valued at about $28,000. Darwin Wealth Management LLC purchased a new position in shares of American Healthcare REIT in the 2nd quarter worth approximately $31,000. Total Investment Management Inc. bought a new position in shares of American Healthcare REIT during the 2nd quarter worth approximately $32,000. Finally, US Bancorp DE lifted its position in American Healthcare REIT by 84.8% during the third quarter. US Bancorp DE now owns 1,085 shares of the company’s stock valued at $46,000 after acquiring an additional 498 shares during the last quarter. 16.68% of the stock is currently owned by hedge funds and other institutional investors.
American Healthcare REIT Company Profile
American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.
Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.
See Also
- Five stocks we like better than American Healthcare REIT
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- Deutsche Bank Just Raised Their Gold Target to $6,000
- NEW: Gold makes history
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
